Trade-offs abound as big pharma makes direct-to-consumer transition
Direct-to-consumer platforms are expanding amid Trump’s pricing pressures, but uptake has hurdles.
Direct-to-consumer platforms are expanding amid Trump’s pricing pressures, but uptake has hurdles.